Article source: MedRobot
Reprinting requirements: It can be reproduced 24 hours after the first release, and the source must be indicated
NO.1 Intuitive medical Ion surgical robot enters the innovation channel
Intuitive Fosun officially announced: On November 15, 2022, the bronchoscopic operation control system independently developed by the American Intuitive Medical Company (Ion Endoluminal) System, hereinafter referred to as "Ion") has passed the review of the State Drug Administration and has been approved to enter the special review process for innovative medical devices.
On October 31, 2022, the Equipment Review Center issued the publication of the review results of the 2022 No. 8 Special Review Application for Innovation Medical Devices, including the "Bronchoscopic Operation Control System" of Intuitive Medical Company (that is, what we often call a bronchoscopic surgical robot, which is a transnatural cavity surgical robot)
As of November 15, 2022, the announcement period ends.
means that the robot Ion through natural cavity surgery has officially entered the innovation channel.
NO.2 Tudao Medical held the first set of orthopedic mass-produced products to be offline
On November 23, 2022, Tuodao Medical held the first set of orthopedic mass-produced products to be offline. This set of products consists of Tuo hand orthopedic surgery robot and mobile C-arm X-ray machine, which marks that Tuodao spinal surgery will be widely used in clinical operations.
Tuo hand orthopedic surgery robot is the first orthopedic surgery robot in China to complete randomized controlled clinical trials with similar products. Its clinical accuracy, surgical effect (excellent rate of screw placement), image display clarity, etc. are all better than clinically controlled products. It combines real-time image navigation technology and robotic technology to intelligently analyze intraoperative image data, independently complete positioning channels, and has a clinical accuracy of sub-mm (<1mm). Compared with traditional surgeries, it has the advantages of high positioning accuracy and small surgical incision, which can help orthopedic surgery become intelligent.
NO.3 Minimally Invasive® Honghu® Orthopedic Surgery Robot successfully completed the first robot-assisted total knee replacement surgery in the United States
On November 22, 2022, MicroPort NaviBot International, a subsidiary of Shanghai Minimally Invasive Robot (Group) Co., Ltd. (hereinafter referred to as "Minimally Invasive® Robot"), an affiliate of Shanghai Minimally Invasive Robot (Group) Co., Ltd. (hereinafter referred to as "Minimally Invasive® Robot"), announced the completion of the first total knee replacement surgery assisted by Honghu® orthopedic Surgery Robot in the United States. The surgery was completed by Dr. Joseph Kavolus of the Surgical Hospital in Hollis Lighthouse, New Hampshire, USA. The hospital is also the first hospital in the United States to complete the installation trial.
This operation was the first total knee replacement surgery successfully performed in the United States after obtaining FDA approval from Minimally Invasive® Honghu® Orthopedic Surgical Robot, and is an important milestone for Minimally Invasive® Robot Group. The smooth implementation of Honghu® orthopedic surgical robots in the overseas market will help Minimally Invasive® Robot Group accelerate its global strategic layout, benefit more global patients, and realize the original intention of "making no difficult surgery in the world."
NO.4 The world's first focal treatment of prostate cancer based on prostate positioning robot combined with cryoablation platform was successfully implemented
November 25, 2022 News, Professor Guo Hongqian's team of the Department of Urology at Gulou Hospital Affiliated to Nanjing University School of Medicine recently completed the world's first focal treatment of prostate cancer based on prostate positioning robot combined with cryoablation platform. The Mona Lisa prostate puncture positioning equipment developed by Shanghai Jiehang Robot Co., Ltd. combined with the cryoablation equipment developed by Shanghai Guixiang Medical System Co., Ltd. makes surgical treatment more accurate. The treatment is accurate in positioning and has little damage, which retains the patient's prostate gland, reduces the risk of surgery and the probability of complications, and obtains a safe, effective and reliable focal treatment method. The success of this surgery marks the clinical validation of the precise therapy of Mona Lisa robot in the field of percutaneous puncture.
NO.5 Zhejiang University First Hospital completed the first domestic 4-arm laparoscopic robot full cavity radical cystectomy + in situ neo-bladder surgery
NO.6 Hainan Province's first domestic robot and Huaruibo assisted total knee replacement surgery
Before surgery, with the help of Hehua intelligent surgical planning system, Director Fu Kun designed an osteotomy suitable for patients based on personalized characteristics such as patient bone morphology, anatomical marks, and dynamic balance after CT scan and three-dimensional reconstruction. During the operation, under the navigation positioning of submillimeter-level precision of the robot, the spatial positions of the patient's femur and tibia were accurately presented on the system coordinate system . robot arm carries the tool to automatically move to each planned osteotomy plane and lock it to ensure that the position and angle of the osteotomy are consistent with the plan. Director Fu Kun conducts real-time confirmation and adjustment of osteotomy based on the patient's knee soft tissue tension and the gap data measured by the robot. The human-machine cooperates efficiently, and the operation is a complete success.
NO.7 Shurui successfully held the first issue of Tianjin Medical University Second Hospital Shurui single-aperoscope surgery robot skills training